Furthermore, artificial intelligence-driven clustering of SOX expression with tumor mutational burden (TMB) and immune signatures may help identify resistance patterns or novel biomarkers, while bioinformatics analysis of SOX3 methylation may demonstrate diagnostic value (60,61). The gene discussed is SOX3; the disease is neoplasm.